DrugsControl Media Services

News Detail

NCC-MvPI identifies 119 new MDAEM centres in various states to report adverse events (27-01-2023)

Mumbai, 27 Jan 2023: The Ghaziabad-based Indian Pharmacopoeia Commission (IPC) which is the national co-coordinating centre (NCC) for the Materiovigilance Programme of India (MvPI) has identified 119 new Medical Device Adverse Event Monitoring (MDAEM) centres in various states to......
View Details

Source : Pharmabiz
Indian Pharmacopoeia Commission IPC national co-coordinating centre NCC Materiovigilance Programme of India MvPI MDAEM IPC SAEs SCTIMST NHSRC cardiac orthopaedic

Related News